Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 47, Issue 2, 2012, Pages 236-242

  Mohty, B ^a,b   Thomas, Y ^a   Vukicevic, M ^a,b   Nagy, M ^a,b   Levrat, E ^a,b   Bernimoulin, M ^a,b   Kaiser, L ^a   Roosnek, E ^a,b   Passweg, J ^a,b   Chalandon, Y ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

allogeneic hematopoietic SCT; infection; influenza A H1N1; oseltamivir; swine flu

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; PREDNISONE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TOLERABILITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; THORAX RADIOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 84857032071     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.57     Document Type: Article

References (43)

1. Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11: 781-796. (Pubitemid 41403760)
2. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484. (Pubitemid 33069626)
3. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306. (Pubitemid 39458515)
4. Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009; 11: 100-105.
5. Martino R, Ramila E, Rabella N, Munoz JM, Peyret M, Portos JM et al. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis 2003; 36: 1-8. (Pubitemid 36099089)
6. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201.
7. CDC. Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 467-470.
8. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362: 1708-1719.
9. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361: 2507-2517.
10. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
11. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-689.
12. Garbino J, Gerbase MW, Wunderli W, Kolarova L, Nicod LP, Rochat T et al. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 2004; 125: 1033-1039. (Pubitemid 38367297)
13. World Health Organization. CDC Protocol of Realtime RT-PCR for Swine Influenza A (H1N1). World Health Organization: Geneva, Accessed 30 November 2009, at http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/ en.2009.
14. De la Camara R, Cannata J, Nieto J, Gonzalez-Vicent M, Lassaletta A, Garcia-Noblejas A et al. Novel swine-origin influenza A (H1N1) in SCT and onco-haematological patients: clinical characteristics and outcome in 87 confirmed cases. Bone Marrow Transplant 2010; 45(suppl 2): S35-S36. (Abstract 224).
15. Ljungman P. H1N1 Infections In Hematopoietic Stem Cell Transplant Recipients: A Prospective Study, ICAAC Meeting 2010. Abstract.
16. George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2010; 17: 147-153.
17. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010; 60: 257-263.
18. Taplitz R, Espinosa-Aguilar L, Green J, Forrest G, Ball E, Maziarz R et al. Novel H1N1 influenza in hematopoietic stem cell transplant recipients: two center's experience. Biol Blood Marrow Transplant (e-pub ahead of print 10 August 2010).
19. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16: 1068-1075.
20. Chalandon Y, Roosnek E, Mermillod B, Waelchli L, Helg C, Chapuis B. Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study. Biol Blood Marrow Transplant 2006; 12: 102-110. (Pubitemid 43034103)
21. OFSP. Rapport de situation hebdomdaire de l'OFSP. http://www.bag.admin. ch/dokumentation/publikationen/01435/07914/index.html?lang.fr. Accessed online 9 September 2010.
22. Ljungman P. Solid-organ transplants and the risks of pandemic influenza. Lancet Infect Dis 2010; 10: 506-507.
23. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-2615.
24. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375: 1100-1108.
25. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361: 2619-2627.
26. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
27. Patel P, Sweiss K, Shatavi S, Peace D, Clark N, Rondelli D. The impact of novel influenza A (H1N1) after hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1756-1757.
28. Ditschkowski M, Elmaagacli AH, Beelen DW. H1N1 in allogeneic stem cell recipients: courses of infection and influence of vaccination on graft-versus-host-disease (GVHD). Ann Hematol 2010; 90: 117-118.
29. Garland P, de Lavallade H, Sekine T, Hoschler K, Sriskandan S, Patel P et al. Humoral and cellular immunity to primary H1N1 infection in patients with hematological malignancies and following stem cell transplantation. Biol Blood Marrow Transplant (e-pub ahead of print 10 August 2010).
30. CDC. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 893-896.
31. Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, Sandin R. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 2010; 91: 124-127.
32. Rozovski U, Herishanu Y, Gipstein L, Naparstek E. Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant 2010; 45: 1572-1573.
33. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278-287. (Pubitemid 44401460)
34. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1-5. (Pubitemid 23086839)
35. Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30: 342-348. (Pubitemid 30131544)
36. Avetisyan G, Aschan J, Hassan M, Ljungman P. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation 2008; 86: 257-263.
37. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375: 41-48.
38. Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P et al. Viral disease prevention after hemato-poietic cell transplantation. Bone Marrow Transplant 2009; 44: 471-482.
39. Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521-526.
40. Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 2010; 61: 270-272.
41. Bastos DA, Rodrigues CA, Patah P, Kallas EG, Rocha V, Novis Y. Pandemic influenza A H1N1/09 virus infection in hematopoietic SCT recipient. Bone Marrow Transplant 2010 (e-pub ahead of print 7 June 2010; doi:10.1038/bmt.2010.133).
42. Frangoul H, Domm J, Denison MR, Calder C, Black J. H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT. Bone Marrow Transplant 2010; 46: 152-153.
43. Campbell AP, Jacob ST, Kuypers J, Wald A, Englund JA, Corey L et al. Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: detection of extrapulmonary H1N1 RNA and use of intravenous peramivir. Ann Intern Med 2010; 152: 619-620.